Articles
Volume 13 Supplement 2
IX Madrid Breast Cancer Conference
Meeting abstracts
IX Madrid Breast Cancer Conference
Madrid, Spain
16-17 November 2011
|
L Pusztai Breast Cancer Research 2011, 13(Suppl 2):O1 (16 November 2011) |
|
Molecular classification of triple-negative tumors A Prat, CM Perou Breast Cancer Research 2011, 13(Suppl 2):O2 (16 November 2011) |
|
Poly(ADP-ribose) polymerase inhibitor development: are we in the right direction? R Plummer Breast Cancer Research 2011, 13(Suppl 2):O3 (16 November 2011) |
|
Epithelial-mesenchymal transition as a mechanism for the progression of breast carcinoma JP Thiery, WJ Sim, K Chua, R Huang, S Mori, T Tan, FC Bidart, JY Pierga Breast Cancer Research 2011, 13(Suppl 2):O5 (16 November 2011) |
|
M Esteller Breast Cancer Research 2011, 13(Suppl 2):O6 (16 November 2011) |
|
Immunity and autoimmunity in breast cancer G Curigliano Breast Cancer Research 2011, 13(Suppl 2):O4 (16 November 2011) |
|
Insulin resistance in breast cancer: relevance and clinical implications PJ Goodwin Breast Cancer Research 2011, 13(Suppl 2):O7 (16 November 2011) |
|
The phosphatidylinositol-3 kinase/mTOR pathway: new agents CL Arteaga Breast Cancer Research 2011, 13(Suppl 2):O8 (16 November 2011) |
|
DNA repair and breast cancer: therapeutic opportunities DP Silver Breast Cancer Research 2011, 13(Suppl 2):O9 (16 November 2011) |
|
NoncodingRNAs: from bench to bedside GA Calin Breast Cancer Research 2011, 13(Suppl 2):O10 (16 November 2011) |
|
Targeting HER2 in breast cancer: beyond trastuzumab EP Winer Breast Cancer Research 2011, 13(Suppl 2):O11 (16 November 2011) |
|
J Baselga, F Costa, H Gomez, C Hudis, B Rapoport, H Roche, LS Schwartzberg, O Petrenciuc, M Shan, WJ Gradishar Breast Cancer Research 2011, 13(Suppl 2):O12 (16 November 2011) |
|
Molecular heterogeneity of luminal breast cancer S Loi Breast Cancer Research 2011, 13(Suppl 2):O13 (16 November 2011) |
|
Translational breast cancer research in luminal breast cancer M Dowsett Breast Cancer Research 2011, 13(Suppl 2):O14 (16 November 2011) |
|
Interpretation and molecular validation of biomarker studies JS Reis-Filho Breast Cancer Research 2011, 13(Suppl 2):O15 (16 November 2011) |
|
Clinical features and prognosis of tubular breast cancer M Izquierdo Sanz, F Tresserra Casas, G Nacho RodrÃguez, R Fabregas Xaurado, M Cusido Gimferrer, C Ara Perez, S Baulies Caballero Breast Cancer Research 2011, 13(Suppl 2):P1 (16 November 2011) |
|
Breast Cancer Research 2011, 13(Suppl 2):P2 (16 November 2011) |
|
Nestin and collagen triple helix repeat containing 1 in breast cancer progression G Kharaishvili, D Simkova, M Cizkova, K Bouchalova, G Mgebrishvili, Z Kolar, J Bouchal Breast Cancer Research 2011, 13(Suppl 2):P3 (16 November 2011) |
|
L Manso, E Ciruelos, M Codes, J De la Haba, A Galan, J Baena, A Jaen, M Gil, A Murias, I Blancas, E Gonzalez, D Perez, JL Bayo, J Mel, E Garcia-Martinez, R Cubedo, J Salvador Breast Cancer Research 2011, 13(Suppl 2):P4 (16 November 2011) |
|
JWK Lee, CTM Ong, EY Tan, MYP Chan Breast Cancer Research 2011, 13(Suppl 2):P5 (16 November 2011) |

